Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|December 2, 2011
MF59 adjuvanted seasonal and pandemic influenza vaccinesTheodore F TsaiInfection & Chemotherapy|November 23, 2013
Fluad®-MF59®-Adjuvanted Influenza Vaccine in Older AdultsTheodore F TsaiHuman Vaccines & Immunotherapeutics|January 19, 2012
New technologies for influenza vaccinesPhilip R Dormitzer, Theodore F Tsai, Giuseppe Del GiudiceEmerging Infectious Diseases|July 24, 2023
Advanced Age and Increased Risk for Severe Outcomes of Dengue Infection, Taiwan, 2014-2015Nicole Huang, Yi Jung Shen, Yiing Jenq Chou, et al.Scandinavian Journal of Infectious Diseases|May 4, 2011
Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsyTheodore F Tsai, Antonio Crucitti, Pantaleo Nacci, et al.The Pediatric Infectious Disease Journal|April 29, 2006
Invasive pneumococcal disease burden in Hong Kong childrenPak Leung Ho, Susan S Chiu, Chris H Y Cheung, et al.Emerging Infectious Diseases|December 19, 2001
Advanced age a risk factor for illness temporally associated with yellow fever vaccinationMichael Martin, Leisa H Weld, Theodore F Tsai, et al.NPJ Vaccines|October 17, 2018
Cell culture-derived influenza vaccines in the severe 2017-2018 epidemic season: a step towards improved influenza vaccine effectivenessIan G Barr, Ruben O Donis, Jacqueline M Katz, et al.The New England Journal of Medicine|October 15, 2011
Oil-in-water emulsion adjuvant with influenza vaccine in young childrenTimo Vesikari, Markus Knuf, Peter Wutzler, et al.Plos One|May 3, 2013
Altered response to A(H1N1)pnd09 vaccination in pregnant women: a single blinded randomized controlled trialAnne Louise Bischoff, Nilofar Vahman Følsgaard, Charlotte Giwercman Carson, et al.Pageof 2